GO:0045098 type III intermediate filament: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045098 defines the type III intermediate filament (IF) as a cytoskeletal polymer built from vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin, which can form both homo- and heteropolymeric filaments.
• Type III IF proteins are not passive structural elements; they act as targets and effectors of electrophiles and oxidants, with a conserved cysteine residue playing a key redox-sensing role.
• Peripherin, a type III IF protein, regulates lysosomal degradation activity and autophagy, linking the cytoskeleton to membrane trafficking and proteostasis.
• Plasma GFAP, a type III IF protein, is a promising biomarker for predicting clinical progression in nervous system diseases.
• Transgenic and mutant mouse models have been essential for dissecting type III IF gene function in vivo, revealing roles in development and tissue integrity.
• Type III IF proteins are novel CoAlation targets, expanding their involvement in redox regulation and cellular stress responses.
Description
Type III intermediate filaments (IFs) are a subclass of the intermediate filament cytoskeleton defined by their protein composition and assembly properties. According to the Gene Ontology, GO:0045098 (type III intermediate filament) refers to a filament typically made up of one or more of the proteins vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Unlike keratins, type III IF proteins can form both homopolymeric and heteropolymeric filaments, providing structural and functional diversity across cell types. These filaments are essential for mechanical support, cell shape, and tissue integrity, and they are increasingly recognized as dynamic regulators of signaling and stress responses. Researchers study type III IFs because they are implicated in a wide range of physiological and pathological processes, from neuromuscular disorders to neurodegeneration and cancer. Their unique redox sensitivity, mediated by conserved cysteine residues, positions them as key players in cellular responses to oxidative stress. Understanding the biology of type III IFs at the molecular, cellular, and organismal levels is therefore critical for both basic cell biology and translational medicine.
type III intermediate filament At A Glance
| GO ID | GO:0045098 |
|---|---|
| GO term | type III intermediate filament |
| Ontology | cellular_component |
| Synonym | desmin, glial fibrillary acidic protein, peripherin, type III intermediate filament associated protein, vimentin |
| Major function | Structural support, mechanical integrity, and regulation of cellular stress responses |
| Protein components | Vimentin, desmin, GFAP, peripherin |
| Assembly property | Can form homo- and heteropolymeric filaments |
| Redox sensitivity | Contains conserved cysteine residues that act as redox sensors |
| Disease relevance | Implicated in neuromuscular disorders, neurodegeneration, and cancer |
What Is GO:0045098?
GO:0045098 (type III intermediate filament) is a cellular component term describing a type of intermediate filament that is typically composed of one or more of the proteins vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Unlike keratins, the type III proteins can form both homo- and heteropolymeric IF filaments. This definition highlights the compositional flexibility and structural role of these filaments in the cytoskeleton.
Why Is type III intermediate filament Important in Cell Biology?
Type III intermediate filaments are important because they provide essential mechanical support to cells and tissues while also participating in dynamic processes such as redox signaling, autophagy regulation, and disease progression. Their unique ability to form homo- and heteropolymeric filaments allows for functional specialization across different cell types, and their conserved cysteine residues make them sensitive to oxidative modifications that can alter cellular behavior. As biomarkers and therapeutic targets, type III IF proteins are increasingly relevant in neurology, oncology, and regenerative medicine.
• Maintains cell and tissue mechanical integrity through cytoskeletal networks.
• Acts as a target and effector of electrophiles and oxidants, linking the cytoskeleton to redox signaling.
• Regulates lysosomal degradation and autophagy via peripherin.
• Serves as a plasma biomarker (GFAP) for predicting progression in nervous system diseases.
• Involved in neuromuscular disorders through muscle satellite cell dysfunction.
• Provides a model system for studying intermediate filament assembly and heteropolymerization.
• Participates in CoAlation, a novel redox modification.
• Has implications in osteoarthritis and cartilage homeostasis.
• Enables transgenic and mutant mouse studies to dissect gene function in vivo.
• Offers potential targets for therapeutic intervention in neurodegeneration and cancer.
What Happens During type III intermediate filament?
Assembly and polymerization
In simple terms: Type III IF proteins come together to form long, rope-like filaments that give cells shape and strength.
Type III intermediate filaments assemble from soluble protein subunits into 10-nm filaments. The proteins vimentin, desmin, GFAP, and peripherin can co-assemble into homo- or heteropolymeric filaments, a property that distinguishes them from keratins. This assembly is regulated by phosphorylation and other post-translational modifications, and the resulting filaments provide mechanical resilience to cells.
Redox sensing and modification
In simple terms: These filaments can sense chemical stress and change their behavior in response.
Type III IF proteins contain conserved cysteine residues that act as redox sensors. They are targets and effectors of electrophiles and oxidants, and their modification can alter filament dynamics and cellular signaling. For example, CoAlation, a novel redox modification, occurs on type III IF proteins under oxidative stress.
Regulation of autophagy and lysosomal activity
In simple terms: Peripherin helps control the cell's recycling system.
Peripherin, a type III IF protein, regulates lysosomal degradation activity and autophagy. Its presence influences the efficiency of autophagic flux and lysosomal function, linking the cytoskeleton to proteostasis.
Role in disease progression
In simple terms: When these filaments go wrong, they can contribute to nerve and muscle diseases.
Alterations in type III IF proteins are associated with neuromuscular disorders and neurodegeneration. For instance, GFAP levels in plasma can predict clinical progression in nervous system diseases, and muscle satellite cell dysfunction involving type III IFs contributes to neuromuscular disorders.
Key Genes Involved in GO:0045098 type III intermediate filament
The following genes encode the major type III intermediate filament proteins and related factors, each with distinct roles and research relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VIM | Encodes vimentin, a type III IF protein | Marker of mesenchymal cells; involved in cell migration and cancer |
| DES | Encodes desmin, a muscle-specific type III IF protein | Mutations cause desmin-related myopathies; studied in neuromuscular disorders |
| GFAP | Encodes glial fibrillary acidic protein, an astrocyte-specific type III IF protein | Plasma biomarker for nervous system disease progression |
| PRPH | Encodes peripherin, a neuronal type III IF protein | Regulates lysosomal degradation and autophagy |
| LMNA | Encodes lamins A/C, type V IF proteins | Not a type III IF, but often studied in context of IF networks |
| KRT8 | Encodes keratin 8, a type II IF protein | Contrasts with type III IFs in assembly properties |
| KRT18 | Encodes keratin 18, a type I IF protein | Used as a comparison for type III IF heteropolymerization |
| NEFL | Encodes neurofilament light, a type IV IF protein | Another neuronal IF for comparative studies |
| NEFM | Encodes neurofilament medium, a type IV IF protein | Neuronal IF relevant to neurodegeneration |
| NEFH | Encodes neurofilament heavy, a type IV IF protein | Axonal IF for structural studies |
| INA | Encodes alpha-internexin, a type IV IF protein | Neuronal IF development |
| PLEC | Encodes plectin, a cytolinker | Links type III IFs to other cytoskeletal elements |
| DSP | Encodes desmoplakin, a desmosomal protein | Interacts with IFs in cell adhesion |
| JUP | Encodes junction plakoglobin | Desmosomal plaque protein |
| CRYAB | Encodes alphaB-crystallin, a small heat shock protein | Chaperone for type III IFs, prevents aggregation |
| BAG3 | Encodes BAG3, a co-chaperone | Involved in IF protein quality control |
| SQSTM1 | Encodes p62, an autophagy receptor | Links type III IFs to autophagy |
How Is type III intermediate filament Regulated?
Type III intermediate filament assembly and function are regulated by phosphorylation, redox modifications, and interactions with chaperones and cytolinkers. The conserved cysteine residue in type III IF proteins serves as a redox switch, and its modification by electrophiles or oxidants can alter filament dynamics. CoAlation, a novel redox modification, further modulates their behavior under stress. Additionally, phosphorylation by kinases such as CDK1 and Rho-kinase controls filament disassembly during mitosis and cell migration. Chaperones like alphaB-crystallin and BAG3 assist in preventing aggregation and maintaining filament integrity.
type III intermediate filament and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DES | Desmin-related myopathy | Knock-in mouse with DES mutation |
| GFAP | Alexander disease, neurodegeneration | GFAP knockout or point-mutation cells |
| PRPH | Neurodegeneration, autophagy dysfunction | PRPH knockout cell line |
| VIM | Cancer metastasis, EMT | VIM knockout cancer cells |
| CRYAB | Myopathy, cataract | CRYAB knockout mouse |
Neuromuscular disorders
Type III IF proteins, particularly desmin, are critical for muscle integrity. Mutations in DES cause desmin-related myopathies, and muscle satellite cell dysfunction involving type III IFs contributes to neuromuscular disorders. Transgenic mouse models carrying mutated type III IF genes have provided insights into disease mechanisms.
Neurodegeneration and nervous system diseases
GFAP, a type III IF protein, is a biomarker for astrocyte activation and is used to predict clinical progression in nervous system diseases. Peripherin regulates autophagy and lysosomal degradation, processes implicated in neurodegeneration.
Cancer and osteoarthritis
Vimentin expression is associated with epithelial-mesenchymal transition and cancer progression. Orosomucoid 1 has been shown to ameliorate temporomandibular joint osteoarthritis by maintaining cartilage homeostasis, potentially involving type III IF proteins.
From type III intermediate filament-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of vimentin in cell migration? | VIM knockout cell line |
| How does desmin mutation affect muscle function? | DES point-mutation knock-in mouse |
| Does GFAP contribute to astrocyte reactivity? | GFAP knockout mouse |
| How does peripherin regulate autophagy? | PRPH overexpression cell line |
| What is the effect of redox modification on IF assembly? | Point mutation of conserved cysteine in VIM |
| Can type III IFs be tagged for live imaging? | Tagged knock-in of VIM or DES |
How to Study the type III intermediate filament Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Filament assembly and localization | Live-cell imaging of tagged vimentin |
| Electron microscopy | Ultrastructure of filaments | Visualizing IF networks |
| Mass spectrometry | Post-translational modifications | Detecting CoAlation on type III IFs |
| Redox proteomics | Cysteine oxidation | Identifying redox-sensitive cysteines |
| CRISPR-Cas9 knockout | Gene function | Creating VIM or DES knockout cells |
| Transgenic mouse models | In vivo gene function | Studying mutated type III IF genes |
| Plasma GFAP immunoassay | Biomarker levels | Predicting disease progression |
| Autophagy flux assays | Lysosomal degradation activity | Assessing peripherin function |
Imaging and structural analysis
Fluorescence microscopy, including live-cell imaging of tagged type III IF proteins, allows visualization of filament assembly and dynamics. Electron microscopy provides ultrastructural details of filament networks.
Proteomics and redox analysis
Mass spectrometry-based proteomics can identify post-translational modifications such as CoAlation and oxidation on type III IF proteins. Redox proteomics specifically detects cysteine modifications.
Genetic and transgenic models
Transgenic mice carrying chimeric or mutated type III IF genes are used to study function in vivo. CRISPR-Cas9 genome editing enables the creation of knockout and knock-in cell lines and animal models.
Biomarker detection
Plasma GFAP levels are measured by immunoassays to predict clinical progression in nervous system diseases. ELISA and Simoa are commonly used for quantification.
How CRISPR Can Be Used to Study GO:0045098 type III intermediate filament
Knockout
CRISPR-Cas9 knockout of type III IF genes such as VIM, DES, GFAP, or PRPH allows researchers to study loss-of-function phenotypes in cell models. For example, VIM knockout cells have been used to investigate cell migration and mechanical properties.
Point Mutation
Introducing specific point mutations, such as in the conserved cysteine residue of type III IF proteins, helps dissect redox regulation. These models can reveal how oxidation affects filament assembly and function.
Knock-in
Knock-in of tagged versions of type III IF proteins (e.g., GFP-vimentin) enables live-cell imaging and biochemical purification. This approach is valuable for tracking filament dynamics in real time.
Overexpression
Overexpression of type III IF proteins, such as peripherin, can be used to study their effects on autophagy and lysosomal activity. Overexpression models help identify gain-of-function phenotypes.
How EDITGENE Supports type III intermediate filament Research
Researchers studying type III intermediate filament-related genes often need to determine whether a candidate gene is causally involved in cytoskeletal function, stress responses, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for type III intermediate filament research.
Frequently Asked Questions About type III intermediate filament
What is GO:0045098?
GO:0045098 is the Gene Ontology term for type III intermediate filament, a cellular component made of proteins like vimentin, desmin, GFAP, and peripherin.
What genes are involved in type III intermediate filament?
The major genes are VIM (vimentin), DES (desmin), GFAP (glial fibrillary acidic protein), and PRPH (peripherin).
What is the function of type III intermediate filaments?
They provide mechanical support, regulate redox signaling, and participate in autophagy and disease progression.
How are type III intermediate filaments different from keratins?
Unlike keratins, type III IF proteins can form both homo- and heteropolymeric filaments.
What diseases are associated with type III intermediate filaments?
They are linked to neuromuscular disorders, neurodegeneration, and cancer.
How can I study type III intermediate filaments in the lab?
Common methods include CRISPR knockout, live-cell imaging, proteomics, and biomarker assays.
What is the role of vimentin in cells?
Vimentin is a type III IF protein that maintains cell shape and is involved in migration and cancer.
Is GFAP a biomarker for brain injury?
Yes, plasma GFAP is used to predict clinical progression in nervous system diseases.
How does peripherin regulate autophagy?
Peripherin influences lysosomal degradation activity and autophagic flux.
Can type III intermediate filaments be targeted for therapy?
They are potential therapeutic targets in neurodegeneration and cancer, though more research is needed.
Conclusion
Type III intermediate filaments, defined by GO:0045098, are dynamic cytoskeletal structures composed of vimentin, desmin, GFAP, and peripherin. They play critical roles in mechanical support, redox sensing, autophagy regulation, and disease. Understanding their biology offers insights into neuromuscular disorders, neurodegeneration, and cancer, and provides opportunities for therapeutic intervention. EDITGENE's CRISPR services can help researchers dissect the functions of these proteins in health and disease.
References
- 1. Viedma-Poyatos Á et al.. 2020. Type III intermediate filaments as targets and effectors of electrophiles and oxidants.. Redox Biol 36:101582 PMID: 32711378
- 2. Pajares MA et al.. 2024. Type III intermediate filaments in redox interplay: key role of the conserved cysteine residue.. Biochem Soc Trans 52(2):849-860 PMID: 38451193
- 3. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 4. Romano R et al.. 2025. The Type III Intermediate Filament Protein Peripherin Regulates Lysosomal Degradation Activity and Autophagy.. Int J Mol Sci 26(2) PMID: 39859265
- 5. Zheng X et al.. 2024. Prediction of clinical progression in nervous system diseases: plasma glial fibrillary acidic protein (GFAP).. Eur J Med Res 29(1):51 PMID: 38216970
- 6. Bloemendal H et al.. 1997. Transgenic mice carrying chimeric or mutated type III intermediate filament (IF) genes.. Cell Mol Life Sci 53(1):1-12 PMID: 9117989
- 7. Zhang D et al.. 2025. Orosomucoid 1 Ameliorates Temporomandibular Joint Osteoarthritis by Maintaining Cartilage Homeostasis.. Adv Sci (Weinh) 12(36):e00028 PMID: 40583170
- 8. Goya-Iglesias N et al.. 2026. Type III intermediate filaments as novel CoAlation targets.. Redox Rep 31(1):2692797 PMID: 42343562
